Edwards Lifesciences (WBO:EWLS) E10: €2.26 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:EWLS Edwards Lifesciences Corp WBO:EWLS
95 GF Score
Price €80.18
GF Value €83.39
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences E10?

Edwards Lifesciences WBO:EWLS -0.57% 95 E10 is €2.26 as of Jun. 2026. GuruFocus rates WBO:EWLS with a GF Score™ of 95/100 and a GF Value™ of €83.39 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Edwards Lifesciences's adjusted earnings per share data for the three months ended in Jun. 2026 was €0.365. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €2.26 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Edwards Lifesciences's average E10 Growth Rate was 6.20% per year. During the past 3 years, the average E10 Growth Rate was 17.40% per year. During the past 5 years, the average E10 Growth Rate was 20.70% per year. During the past 10 years, the average E10 Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Edwards Lifesciences was 46.50% per year. The lowest was 15.90% per year. And the median was 20.65% per year.

As of today (2026-08-13), Edwards Lifesciences's current stock price is €80.18. Edwards Lifesciences's E10 for the quarter that ended in Jun. 2026 was €2.26. Edwards Lifesciences's Shiller PE Ratio of today is 35.48.

During the past 13 years, the highest Shiller PE Ratio of Edwards Lifesciences was 108.04. The lowest was 28.85. And the median was 64.63.


Edwards Lifesciences  (WBO:EWLS) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Edwards Lifesciences's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=80.18/2.26
=35.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Edwards Lifesciences was 108.04. The lowest was 28.85. And the median was 64.63.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Edwards Lifesciences E10 Related Terms


Edwards Lifesciences E10 Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences E10 Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.12 1.43 1.57 2.27 2.13

Edwards Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.06 2.10 2.13 2.17 2.26

WBO:EWLS vs BSX, DXCM, GEHC: E10 Comparison

For the Medical Devices subindustry, Edwards Lifesciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Shiller PE Ratio falls into.


WBO:EWLS
95GF Score
Edwards Lifesciences Corp WBO:EWLS
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edwards Lifesciences's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.365/333.9520*333.9520
=0.365

Current CPI (Jun. 2026) = 333.9520.

Edwards Lifesciences Quarterly Data

per share eps CPI Adj_EPS
201609 0.193 241.428 0.267
201612 0.231 241.432 0.320
201703 0.330 243.801 0.452
201706 0.255 244.955 0.348
201709 0.221 246.819 0.299
201712 0.048 246.524 0.065
201803 0.260 249.554 0.348
201806 0.377 251.989 0.500
201809 0.303 252.439 0.401
201812 0.009 251.233 0.012
201903 0.348 254.202 0.457
201906 0.336 256.143 0.438
201909 0.390 256.759 0.507
201912 0.396 256.974 0.515
202003 0.443 258.115 0.573
202006 -0.178 257.797 -0.231
202009 0.441 260.280 0.566
202012 0.403 260.474 0.517
202103 0.454 264.877 0.572
202106 0.647 271.696 0.795
202109 0.459 274.310 0.559
202112 0.469 278.802 0.562
202203 0.536 287.504 0.623
202206 0.615 296.311 0.693
202209 0.556 296.808 0.626
202212 0.614 296.797 0.691
202303 0.523 301.836 0.579
202306 0.462 305.109 0.506
202309 0.590 307.789 0.640
202312 0.559 306.746 0.609
202403 0.534 312.332 0.571
202406 0.567 314.175 0.603
202409 4.622 315.301 4.895
202412 0.621 315.605 0.657
202503 0.564 319.799 0.589
202506 0.486 322.561 0.503
202509 0.426 324.800 0.438
202512 0.137 324.054 0.141
202603 0.571 330.213 0.577
202606 0.365 333.952 0.365

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €2.26 mean?
Edwards Lifesciences (WBO:EWLS) has a E10 of €2.26 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' E10 too high?
Edwards Lifesciences' current E10 is €2.26. Overall, Edwards Lifesciences has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' E10 compare to BSX and DXCM?
Edwards Lifesciences' E10 of €2.26 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current E10 is €2.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (WBO:EWLS) is currently considered Fairly Valued. The stock's GF Value™ is €83.39, compared to a current price of €80.18 — trading 3.8% below its estimated fair value. The current E10 is €2.26. Edwards Lifesciences' overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Edwards Lifesciences (WBO:EWLS), the current E10 is €2.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (WBO:EWLS) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of €80.18 is trading 3.8% below its estimated GF Value™ of €83.39. GuruFocus considers Edwards Lifesciences to be Fairly Valued.

Key valuation signals for WBO:EWLS:

  • E10: €2.26
  • GF Value™: €83.39 vs. price of €80.18 (3.8% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the WBO:EWLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
95GF Score

Get the complete analysis for WBO:EWLS

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€80.18
Price
€83.39
GF Value